This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Avery Dennison, Covidien, Tootsie Roll: Ratings Changes

TheStreet.com Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing aims to reduce risk while seeking total return performance.

BOSTON ( TheStreet) -- TheStreet.com's stock-rating model upgraded Avery Dennison (AVY - Get Report), a maker of office supplies, pressure-sensitive materials and labels, to "hold."

The numbers: Second-quarter net income dropped 57% to $40 million and earnings per share fell 59% to 38 cents, hurt by a higher share count. Revenue decreased 20% to $1.5 billion. Its gross margin remained steady at 30%, but its operating margin fell from 8% to 6%. A quick ratio of 0.5 indicates less-than-ideal liquidity. A debt-to-equity ratio of 1.6 indicates excessive leverage.

The stock: Avery Dennison is up 6% this year, trailing major U.S. indices. The company suffered from a $9 a share net loss in the first-quarter and halved its quarterly dividend. Shares pay a 2.3% dividend yield.

The model upgraded Coeur d'Alene Mines (CDE - Get Report) to "hold."

The numbers: The company swung to a second-quarter profit of $12 million, or 17 cents a share, from a loss of $5.4 million, or 10 cents a share, in the year-earlier period. Revenue increased 46% to $73 million. Its gross margin dropped from 50% to 31% and its operating margin remained in negative territory. A quick ratio of 0.5 indicates less-than-ideal liquidity. But a debt-to-equity ratio of 0.1 demonstrates modest leverage.

The stock: Coeur d'Alene Mines has surged 138% this year, outpacing major U.S. indices. The stock trades at a price-to-earnings ratio of 76, a premium to the market and precious metals peers. The company does not pay dividends.

The model upgraded Covidien (COV), maker of health care products and devices, to "buy."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
COV $106.71 -1.26%
AVY $57.72 0.00%
CDE $5.15 0.00%
SPR $52.51 0.00%
TR $30.79 0.00%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs